# A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF

> **NCT06666335** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Swedish Orphan Biovitrum** · enrollment: 3 (estimated)

## Conditions studied

- Familial Mediterranean Fever (FMF )

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT06666335
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-08-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2025-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06666335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06666335, "A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT06666335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*